drugset / Trial / NCT00712270
Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in Schizophrenia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is being conducted to find a way to predict how individual schizophrenic patients will respond if they are treated with different types of antipsychotic drugs. This could help doctors prescribe the medication that will work best for each individual.
Timeline
- Start
- 2005-04
- Primary completion
- 2008-12
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aripiprazole | Other / unclassified | 15 mg | Oral |
| Comparator | Risperidone | Other / unclassified | 2 mg | Oral |